Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro
Date
2011Author
Ermis, Ezgi
Bilir, Ayhan
YAZIHAN, NURAY
Sencan, Mine
Erguven, Mine
Metadata
Show full item recordAbstract
Objective: The aim of the study was to investigate whether lithium chloride and medroxyprogesterone acetate can potentiate the cytotoxicity of imatinib mesylate in human endometrial cancer in vitro and the effect of midkine in these therapies.
Collections
- Makale [92796]